Third Annual Global Bioexcutive Program
Written by Kristie Prinz on Friday, November 25th, 2005
Module One of the Third Annual Global Bioexecutive Program entitled Managing Risk in Development & Commercialization will be held February 8-10, 2006 at UC Berkeley’s Haas School of Business. The course will address the R&D and Pre-Clinical Testing Phases, the Clinical Testing Phases, and the Commercialization Phases in drug development.
Category: Biotech Industry Events
